Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Not applicableActive Not RecruitingNCT06504615What this trial is testingObservational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in FranceWho this might be right forGastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more Bristol-Myers Squibb 208
Testing effectiveness (Phase 2)Ended earlyNCT06206278What this trial is testingEvaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma LianBio LLC 6
Large-scale testing (Phase 3)Study completedNCT02578368What this trial is testingChemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionWho this might be right forGastric Cancer Krankenhaus Nordwest 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157892What this trial is testingDisitamab Vedotin With Other Anticancer Drugs in Solid TumorsWho this might be right forBreast NeoplasmsGastroesophageal Junction AdenocarcinomaHER2 Low Breast Neoplasms+7 more Seagen, a wholly owned subsidiary of Pfizer 54
Large-scale testing (Phase 3)Looking for participantsNCT07673887What this trial is testingASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerWho this might be right forGastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma Astellas Pharma Global Development, Inc. 570
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294What this trial is testingAnti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Akeso 294
Testing effectiveness (Phase 2)Study completedNCT00073502What this trial is testingPhase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) CancerWho this might be right forGastroesophageal AdenocarcinomaGastric Adenocarcinoma OSI Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT03941873What this trial is testingInvestigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction CancerWho this might be right forCarcinoma, HepatocellularGastric/Gastroesophageal Junction Cancer BeiGene 111
Testing effectiveness (Phase 2)Study completedNCT00514020What this trial is testingFluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Vanderbilt-Ingram Cancer Center 33
Not applicableAvailableNCT06048081What this trial is testingEarly Access Program for ZolbetuximabWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06329973What this trial is testingFruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ CancerWho this might be right forMetastatic Gastroesophageal Junction Adenocarcinoma Henan Cancer Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06871527What this trial is testingFruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric CancerWho this might be right forGastric (Stomach) CancerGastric AdenocarcinomaFruquintinib+3 more Sixth Affiliated Hospital, Sun Yat-sen University 44
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070What this trial is testingA Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaWho this might be right forGastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma Ono Pharmaceutical Co., Ltd. 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604What this trial is testingInvestigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2Who this might be right forGastric CancerGastroesophageal Junction Cancer AstraZeneca 33
Early research (Phase 1)Study completedNCT04086758What this trial is testingA Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Astellas Pharma China, Inc. 12
Large-scale testing (Phase 3)Ended earlyNCT01697072What this trial is testingFirst-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric Cancer Amgen 609
Testing effectiveness (Phase 2)Looking for participantsNCT07529808What this trial is testingPhase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaWho this might be right forGastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more BigHat Biosciences, Inc. 164